Drugs / Trivalent OPV
Trivalent OPV
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT01633216 Comparator | May → Dec 2012 | — | International Centre for Diarrhoeal Disease Research, Bangladesh | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Trivalent OPV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01633216 ↗ |
| Known as | tOPV | “trivalent oral polio vaccine (tOPV) given at 4 week intervals” NCT01633216 ↗ |
| Known as | trivalent oral polio vaccine | “trivalent oral polio vaccine (tOPV) given at 4 week intervals” NCT01633216 ↗ |
| Modality | Vaccine | “three types of oral poliovirus vaccine trivalent OPV (tOPV), monovalent OPV type 1 (mOPV1), bivalent OPV types 1 and 3 (bOPV)” NCT01633216 ↗ |
| Route | Oral | “three types of oral poliovirus vaccine” NCT01633216 ↗ |